| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,873 |
2,847 |
$281K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,538 |
3,839 |
$226K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,017 |
927 |
$148K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,689 |
2,863 |
$138K |
| 80053 |
Comprehensive metabolic panel |
6,714 |
5,443 |
$104K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,643 |
2,008 |
$95K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,176 |
3,375 |
$85K |
| 84484 |
|
3,884 |
2,790 |
$82K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,443 |
5,694 |
$76K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
256 |
236 |
$68K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,078 |
2,348 |
$63K |
| 71045 |
Radiologic examination, chest; single view |
3,094 |
2,522 |
$61K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,572 |
2,748 |
$56K |
| 71046 |
Radiologic examination, chest; 2 views |
1,304 |
1,195 |
$41K |
| 83690 |
|
2,297 |
1,977 |
$41K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,147 |
1,846 |
$38K |
| 83880 |
|
2,070 |
1,673 |
$34K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
75 |
65 |
$29K |
| 82550 |
|
2,185 |
1,628 |
$29K |
| 82553 |
|
1,058 |
646 |
$26K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,121 |
616 |
$25K |
| 83735 |
|
2,216 |
1,776 |
$24K |
| 36415 |
Collection of venous blood by venipuncture |
9,489 |
6,916 |
$23K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
515 |
450 |
$23K |
| 83605 |
|
2,563 |
2,136 |
$22K |
| G0378 |
Hospital observation service, per hour |
376 |
225 |
$22K |
| 87040 |
|
1,002 |
727 |
$22K |
| 82248 |
|
1,863 |
1,646 |
$21K |
| 80061 |
Lipid panel |
995 |
927 |
$21K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,542 |
1,420 |
$20K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
570 |
518 |
$19K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
688 |
509 |
$19K |
| 85027 |
|
2,824 |
2,175 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,135 |
1,677 |
$17K |
| 82803 |
|
392 |
308 |
$15K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
163 |
125 |
$12K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
572 |
518 |
$12K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
567 |
436 |
$11K |
| 81001 |
|
2,358 |
2,059 |
$11K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
123 |
113 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
92 |
73 |
$8K |
| 81003 |
|
876 |
791 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
654 |
614 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
953 |
847 |
$7K |
| 85610 |
|
850 |
699 |
$6K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
310 |
187 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,368 |
1,158 |
$6K |
| 0099U |
|
12 |
12 |
$5K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
52 |
50 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
261 |
216 |
$5K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
110 |
85 |
$4K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
2,445 |
1,872 |
$4K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
46 |
41 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
248 |
230 |
$4K |
| 85007 |
|
1,442 |
1,143 |
$4K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
48 |
47 |
$3K |
| 96376 |
|
277 |
184 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
58 |
48 |
$3K |
| 71250 |
|
14 |
12 |
$3K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
135 |
95 |
$2K |
| 80050 |
General health panel |
28 |
26 |
$2K |
| 85730 |
|
216 |
192 |
$2K |
| 87186 |
|
259 |
239 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,622 |
1,425 |
$2K |
| 73630 |
|
34 |
28 |
$1K |
| 96367 |
|
97 |
77 |
$1K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
334 |
169 |
$1K |
| 82962 |
|
166 |
88 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
297 |
236 |
$1K |
| 74022 |
|
20 |
15 |
$950.84 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
12 |
12 |
$934.20 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
29 |
25 |
$828.12 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
58 |
53 |
$757.29 |
| 87077 |
|
95 |
88 |
$688.55 |
| 82150 |
|
40 |
40 |
$586.98 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28 |
28 |
$586.66 |
| 85379 |
|
59 |
56 |
$471.63 |
| 87581 |
|
53 |
51 |
$469.99 |
| 73030 |
|
16 |
13 |
$465.21 |
| 87486 |
|
52 |
50 |
$462.64 |
| 82607 |
|
27 |
24 |
$442.63 |
| 83540 |
|
53 |
49 |
$436.44 |
| 82805 |
|
29 |
29 |
$398.09 |
| 82948 |
|
47 |
26 |
$325.61 |
| 86922 |
|
13 |
13 |
$323.11 |
| 36600 |
|
31 |
30 |
$251.07 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
83 |
43 |
$241.92 |
| 36430 |
|
13 |
13 |
$241.53 |
| 94760 |
|
29 |
12 |
$225.24 |
| 82570 |
|
44 |
40 |
$211.27 |
| 87205 |
|
39 |
38 |
$174.38 |
| 87088 |
|
12 |
12 |
$173.77 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
16 |
16 |
$168.07 |
| J2704 |
Injection, propofol, 10 mg |
32 |
28 |
$157.29 |
| 94761 |
|
26 |
14 |
$155.92 |
| 82043 |
|
14 |
13 |
$147.56 |
| 82728 |
|
14 |
12 |
$126.86 |
| 87070 |
|
14 |
14 |
$117.94 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
24 |
14 |
$111.16 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
31 |
25 |
$102.00 |
| 86140 |
|
15 |
12 |
$89.75 |
| 94664 |
|
18 |
12 |
$81.76 |
| 86850 |
|
14 |
14 |
$75.15 |
| 86901 |
|
13 |
13 |
$71.53 |
| 86900 |
|
13 |
13 |
$71.52 |
| 85652 |
|
12 |
12 |
$69.43 |
| J1940 |
Injection, furosemide, up to 20 mg |
56 |
39 |
$68.08 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
14 |
13 |
$61.67 |
| J3490 |
Unclassified drugs |
390 |
130 |
$27.39 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
22 |
14 |
$15.62 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17 |
12 |
$9.34 |
| C9113 |
Injection, pantoprazole sodium, per vial |
21 |
12 |
$3.07 |